Glide Pharmaceutical Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Out of Business

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Glide Pharmaceutical General Information

Description

Developer of a pharmaceutical development and device platform designed to offer needle-free injectors. The company's platform focuses on the needle-free administration of solid dose formulation of therapeutics and vaccines, that includes octreotide, teriparatide, exenatide and anthrax and influenza vaccines, enabling physicians improve treatment experiences of both patients and carers.

Contact Information

Website
www.glidepharma.com
Formerly Known As
Caretek Medical
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 45B/C Western Avenue
  • Milton Park, Oxfordshire
  • Abingdon OX14 4RU
  • England, United Kingdom
+44 01235
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 45B/C Western Avenue
  • Milton Park, Oxfordshire
  • Abingdon OX14 4RU
  • England, United Kingdom
+44 01235

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glide Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Admin/Reorg 31-Aug-2017 Completed Bankruptcy: Admin/Reorg
9. Later Stage VC 01-Feb-2017 Completed Generating Revenue
8. Later Stage VC 12-Mar-2013 Completed Generating Revenue
7. Grant 05-Nov-2012 Completed Generating Revenue
6. Grant 01-Jun-2012 Completed Generating Revenue
5. Later Stage VC 10-Feb-2010 Completed Generating Revenue
4. Later Stage VC 23-Oct-2008 Completed Generating Revenue
3. Later Stage VC (Series C) 13-Aug-2007 Completed Generating Revenue
2. Early Stage VC 06-Dec-2005 $3.63M $4.68M Completed Startup
1. Early Stage VC 24-Mar-2005 $1.05M $1.05M Completed Startup
To view Glide Pharmaceutical’s complete valuation and funding history, request access »

Glide Pharmaceutical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
Ordinary 4
Ordinary 3
Ordinary 2
Ordinary 1 274,870 $0.000152 $7.63 $7.63 1x $7.63 2.8%
B Ordinary 42,956 $0.000152 $7.07 $7.07 1x $7.07 0.44%
To view Glide Pharmaceutical’s complete cap table history, request access »

Glide Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pharmaceutical development and device platform designed to offer needle-free injectors. The company's pla
Drug Delivery
Abingdon, United Kingdom
22 As of 2016

Orth An Der Donau, Austria
 

Goch, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Glide Pharmaceutical Competitors (4)

One of Glide Pharmaceutical’s 4 competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Manufacturing Austria Corporation Orth An Der Donau, Austria
DFE Pharma Private Equity-Backed Goch, Germany
Pfizer Pakistan Corporation Karachi, Pakistan
Ability Pharma Private Equity-Backed Barcelona, Spain
To view Glide Pharmaceutical’s complete competitors history, request access »

Glide Pharmaceutical Patents

  • 43

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

Glide Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201518594-D0 Solid formation Inactive 20-Oct-2015
GB-2545880-A Solid formulation Inactive 20-Oct-2015
GB-201501697-D0 Injection device Inactive 02-Feb-2015
JP-2021058682-A Injection device Active 02-Feb-2015
GB-201101087-D0 Drug delivery technology Inactive 21-Jan-2011 A61M37/0069
To view Glide Pharmaceutical’s complete patent history, request access »

Glide Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Glide Pharmaceutical FAQs

  • When was Glide Pharmaceutical founded?

    Glide Pharmaceutical was founded in 2001.

  • Where is Glide Pharmaceutical headquartered?

    Glide Pharmaceutical is headquartered in Abingdon, United Kingdom.

  • What is the size of Glide Pharmaceutical?

    Glide Pharmaceutical has 22 total employees.

  • What industry is Glide Pharmaceutical in?

    Glide Pharmaceutical’s primary industry is Drug Delivery.

  • Is Glide Pharmaceutical a private or public company?

    Glide Pharmaceutical is a Private company.

  • What is Glide Pharmaceutical’s current revenue?

    The current revenue for Glide Pharmaceutical is .

  • How much funding has Glide Pharmaceutical raised over time?

    Glide Pharmaceutical has raised $43.1M.

  • Who are Glide Pharmaceutical’s competitors?

    Pfizer Manufacturing Austria, DFE Pharma, Pfizer Pakistan, and Ability Pharma are competitors of Glide Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »